1 Sall K, "Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group" 107 : 631-639, 2000
2 Nichols KK, "The lack of association between signs and symptoms in patients with dry eye disease" 23 : 762-770, 2004
3 Nelson JD, "The international workshop on meibomian gland dysfunction:report of the definition and classification subcommittee" 52 : 1930-1937, 2011
4 "The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Work-Shop (2007)" 5 : 93-107, 2007
5 "The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)" 5 : 75-92, 2007
6 Lemp MA, "Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes" 21 : 221-232, 1995
7 Schiffman RM, "Reliability and validity of the Ocular Surface Disease Index" 118 : 615-621, 2000
8 Han SB, "Prevalence of dry eye disease in an elderly Korean population" 129 : 633-638, 2011
9 Barber LD, "Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years" 112 : 1790-1794, 2005
10 "Methodologies to diagnose and monitor dry eye disease:report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)" 5 : 108-152, 2007
1 Sall K, "Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group" 107 : 631-639, 2000
2 Nichols KK, "The lack of association between signs and symptoms in patients with dry eye disease" 23 : 762-770, 2004
3 Nelson JD, "The international workshop on meibomian gland dysfunction:report of the definition and classification subcommittee" 52 : 1930-1937, 2011
4 "The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye Work-Shop (2007)" 5 : 93-107, 2007
5 "The definition and classification of dry eye disease: report of the Definition and Classification Subcommittee of the International Dry Eye WorkShop (2007)" 5 : 75-92, 2007
6 Lemp MA, "Report of the National Eye Institute/Industry workshop on clinical trials in dry eyes" 21 : 221-232, 1995
7 Schiffman RM, "Reliability and validity of the Ocular Surface Disease Index" 118 : 615-621, 2000
8 Han SB, "Prevalence of dry eye disease in an elderly Korean population" 129 : 633-638, 2011
9 Barber LD, "Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years" 112 : 1790-1794, 2005
10 "Methodologies to diagnose and monitor dry eye disease:report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)" 5 : 108-152, 2007
11 "Management and therapy of dry eye disease: report of the Management and Therapy Subcommittee of the International Dry Eye WorkShop (2007)" 5 : 163-178, 2007
12 Bron AJ, "Grading of corneal and conjunctival staining in the context of other dry eye tests" 22 : 640-650, 2003
13 Perry HD, "Evaluation of topical cyclosporine for the treatment of dry eye disease" 126 : 1046-1050, 2008
14 Behrens A, "Dysfunctional tear syndrome:a Delphi approach to treatment recommendations" 25 : 900-907, 2006
15 Nichols KK, "Association of clinical diagnostic tests and dry eye surveys: the NEI-VFQ-25 and the OSDI" 506 (506): 1177-1181, 2002
16 Wilson SE, "Agreement of physician treatment practices with the international task force guidelines for diagnosis and treatment of dry eye disease" 26 : 284-289, 2007
17 Baiza-Duran L, "A comparative clinical trial of the efficacy of two different aqueous solutions of cyclosporine for the treatment of moderate-to-severe dry eye syndrome" 94 : 1312-1315, 2010